Synthesis and structure-activity relationships of andrographolide analogues as novel cytotoxic agents. 2004

Srinivas Nanduri, and Vijay Kumar Nyavanandi, and Siva Sanjeeva Rao Thunuguntla, and Sridevi Kasu, and Mahesh Kumar Pallerla, and P Sai Ram, and Sriram Rajagopal, and R Ajaya Kumar, and Rajagopalan Ramanujam, and J Moses Babu, and Krishnamurthi Vyas, and A Sivalakshmi Devi, and G Om Reddy, and Venkateswarlu Akella
Discovery Chemistry, Dr. Reddy's Laboratories Ltd, Discovery Research, Bollaram Road, Miyapur, Hyderabad 500 049, India. nandurisrinivas@drreddys.com

Andrographolide 1, the cytotoxic agent of the plant Andrographis paniculata was subjected to semi-synthetic studies leading to the preparation of a number of potent and novel analogues. Of the analogues synthesized, while 8,17-epoxy andrographolide 6 retained the cytotoxic activity of 1, ester derivatives of 6 exhibited considerable improvement in activity. Lower activity was observed when the epoxy moiety in the triacetate 9, derived from 6 was modified. Synthesis and structure-activity relationships are discussed.

UI MeSH Term Description Entries
D004224 Diterpenes Twenty-carbon compounds derived from MEVALONIC ACID or deoxyxylulose phosphate. Diterpene,Diterpenes, Cembrane,Diterpenes, Labdane,Diterpenoid,Labdane Diterpene,Norditerpene,Norditerpenes,Norditerpenoid,Cembranes,Diterpenoids,Labdanes,Norditerpenoids,Cembrane Diterpenes,Diterpene, Labdane,Labdane Diterpenes
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies

Related Publications

Srinivas Nanduri, and Vijay Kumar Nyavanandi, and Siva Sanjeeva Rao Thunuguntla, and Sridevi Kasu, and Mahesh Kumar Pallerla, and P Sai Ram, and Sriram Rajagopal, and R Ajaya Kumar, and Rajagopalan Ramanujam, and J Moses Babu, and Krishnamurthi Vyas, and A Sivalakshmi Devi, and G Om Reddy, and Venkateswarlu Akella
December 2019, Bioorganic & medicinal chemistry letters,
Srinivas Nanduri, and Vijay Kumar Nyavanandi, and Siva Sanjeeva Rao Thunuguntla, and Sridevi Kasu, and Mahesh Kumar Pallerla, and P Sai Ram, and Sriram Rajagopal, and R Ajaya Kumar, and Rajagopalan Ramanujam, and J Moses Babu, and Krishnamurthi Vyas, and A Sivalakshmi Devi, and G Om Reddy, and Venkateswarlu Akella
December 2013, Archives of pharmacal research,
Srinivas Nanduri, and Vijay Kumar Nyavanandi, and Siva Sanjeeva Rao Thunuguntla, and Sridevi Kasu, and Mahesh Kumar Pallerla, and P Sai Ram, and Sriram Rajagopal, and R Ajaya Kumar, and Rajagopalan Ramanujam, and J Moses Babu, and Krishnamurthi Vyas, and A Sivalakshmi Devi, and G Om Reddy, and Venkateswarlu Akella
April 2010, Bioorganic & medicinal chemistry letters,
Srinivas Nanduri, and Vijay Kumar Nyavanandi, and Siva Sanjeeva Rao Thunuguntla, and Sridevi Kasu, and Mahesh Kumar Pallerla, and P Sai Ram, and Sriram Rajagopal, and R Ajaya Kumar, and Rajagopalan Ramanujam, and J Moses Babu, and Krishnamurthi Vyas, and A Sivalakshmi Devi, and G Om Reddy, and Venkateswarlu Akella
November 2012, ChemMedChem,
Srinivas Nanduri, and Vijay Kumar Nyavanandi, and Siva Sanjeeva Rao Thunuguntla, and Sridevi Kasu, and Mahesh Kumar Pallerla, and P Sai Ram, and Sriram Rajagopal, and R Ajaya Kumar, and Rajagopalan Ramanujam, and J Moses Babu, and Krishnamurthi Vyas, and A Sivalakshmi Devi, and G Om Reddy, and Venkateswarlu Akella
August 2017, European journal of medicinal chemistry,
Srinivas Nanduri, and Vijay Kumar Nyavanandi, and Siva Sanjeeva Rao Thunuguntla, and Sridevi Kasu, and Mahesh Kumar Pallerla, and P Sai Ram, and Sriram Rajagopal, and R Ajaya Kumar, and Rajagopalan Ramanujam, and J Moses Babu, and Krishnamurthi Vyas, and A Sivalakshmi Devi, and G Om Reddy, and Venkateswarlu Akella
December 2018, RSC advances,
Srinivas Nanduri, and Vijay Kumar Nyavanandi, and Siva Sanjeeva Rao Thunuguntla, and Sridevi Kasu, and Mahesh Kumar Pallerla, and P Sai Ram, and Sriram Rajagopal, and R Ajaya Kumar, and Rajagopalan Ramanujam, and J Moses Babu, and Krishnamurthi Vyas, and A Sivalakshmi Devi, and G Om Reddy, and Venkateswarlu Akella
May 2014, Bioorganic & medicinal chemistry letters,
Srinivas Nanduri, and Vijay Kumar Nyavanandi, and Siva Sanjeeva Rao Thunuguntla, and Sridevi Kasu, and Mahesh Kumar Pallerla, and P Sai Ram, and Sriram Rajagopal, and R Ajaya Kumar, and Rajagopalan Ramanujam, and J Moses Babu, and Krishnamurthi Vyas, and A Sivalakshmi Devi, and G Om Reddy, and Venkateswarlu Akella
September 2008, European journal of medicinal chemistry,
Srinivas Nanduri, and Vijay Kumar Nyavanandi, and Siva Sanjeeva Rao Thunuguntla, and Sridevi Kasu, and Mahesh Kumar Pallerla, and P Sai Ram, and Sriram Rajagopal, and R Ajaya Kumar, and Rajagopalan Ramanujam, and J Moses Babu, and Krishnamurthi Vyas, and A Sivalakshmi Devi, and G Om Reddy, and Venkateswarlu Akella
April 1990, Journal of medicinal chemistry,
Srinivas Nanduri, and Vijay Kumar Nyavanandi, and Siva Sanjeeva Rao Thunuguntla, and Sridevi Kasu, and Mahesh Kumar Pallerla, and P Sai Ram, and Sriram Rajagopal, and R Ajaya Kumar, and Rajagopalan Ramanujam, and J Moses Babu, and Krishnamurthi Vyas, and A Sivalakshmi Devi, and G Om Reddy, and Venkateswarlu Akella
February 1998, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!